Autoimmune limbic encephalitis as an emerging pediatric condition: Case report and review of the literature

Journal of Child Neurology

Volumn 26, Issue 2, 2011, Pages 218-222

  McCoy, Bláthnaid ^a   Akiyama, Tomoyuki ^a   Widjaja, Elysa ^a   Go, Cristina ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

autoimmune limbic encephalitis; NMDA; seizures

Indexed keywords

IMMUNOGLOBULIN; LORAZEPAM; MEPREDNISONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; OLANZAPINE; PHENYTOIN; RECEPTOR ANTIBODY; RISPERIDONE; UNCLASSIFIED DRUG;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; COGNITIVE DEFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOTHERAPY; MALE; MENTAL DISEASE; MINIMAL RESIDUAL DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; SEIZURE; TREATMENT OUTCOME;

ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; LIMBIC ENCEPHALITIS; MAGNETIC RESONANCE IMAGING; MALE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 79551644922     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810378536     Document Type: Article

References (14)

1. Corsellis JAN, Goldberg GJ, Norton AR "Limbic encephalitis" and its association with carcinoma of the brain. Brain. 1968 ; 91: 481-496.
2. Gultekin SH, Rosenfeld MR, Voltz R., et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour associations in 50 patients. Brain. 2000 ; 123: 1481-1494.
3. Vincent A., Buckley C., Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004 ; 127: 701-712.
4. Thieben MJ, Lennon VA, Boeve BF, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004 ; 62: 1177-1182.
5. Graus F., Saiz A., Lai M., Bruna J., et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical immunological associations. Neurology. 2008 ; 71: 930-936.
6. Bataller L., Kleopa KA, Wu GF, et al. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007 ; 78: 381-385.
7. Dalmau J., Gleichman AJ, Hughes EG, et al. Anti-NMDAreceptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008 ; 7: 1091-1098.
8. Graus F., Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004 ; 75: 1135-1140.
9. Florance N., Davis R., Lam C., et al. NMDA receptor in children/ adolescents. Ann Neurol. 2009 ; 166: 12-18.
10. Urbach H., Soeder B., Jeub M., et al. Serial MRI of limbic encephalitis. Neuroradiology. 2006 ; 48: 380-386.
11. Niehusmann P., Dalmau J., Rudlowski C., et al. Diagnostic value of NMDA R antibodies in women with new onset epilepsy. Arch Neurol. 2009 ; 66: 458-464.
12. Iizuka T., Sakai F., Ide T., et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome with tumour removal. Neurology. 2008 ; 70: 501-511.
13. Schimmel M., Bien CG, Vincent A., Schenk W., Penzien J. Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child. 2009 ; 94: 314-316.
14. Agrawal S., Vincent A., Jacobson L. Successful treatment of anti NMDA receptor LE in a 22 month old with Plasmapheresis and pharmacological immunomodulation [letter to the editor]. Arch Dis Child. 2010 ; 95: 312.